{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:39:39Z","timestamp":1790746779721,"version":"4.1.0"},"reference-count":63,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,8,20]]},"abstract":"<jats:title>Key Points<\/jats:title><jats:p>LCN2 acts to generate reactive oxygen species, leading to increased DNA strand breaks and apoptosis in normal CD34+ cells. LCN2 promotes the generation of osteoblasts but diminishes adipogenesis, resembling the composition of the MF marrow microenvironment.<\/jats:p>","DOI":"10.1182\/blood-2014-12-618595","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T02:30:05Z","timestamp":1432866605000},"page":"972-982","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":66,"title":["Lipocalin produced by myelofibrosis cells affects the fate of both hematopoietic and marrow microenvironmental cells"],"prefix":"10.1182","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4191-4787","authenticated-orcid":false,"given":"Min","family":"Lu","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine and The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Xia","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine and The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Chun","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsivia","family":"Hochman","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Population Health and Department of Environmental Medicine, New York University School of Medicine, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetizia","family":"Bizzari","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine and The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Aruch","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine and The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Lew","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine and The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rona","family":"Weinberg","sequence":"additional","affiliation":[{"name":"Cellular Therapy Laboratory, New York Blood Center, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith D.","family":"Goldberg","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Department of Population Health and Department of Environmental Medicine, New York University School of Medicine, New York, NY; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Medicine and The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111903402473700_B1","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Swerdlow","year":"2008","edition":"4th ed"},{"key":"2019111903402473700_B2","author":"Mascarenhas"},{"issue":"suppl 1","key":"2019111903402473700_B3","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1186\/1755-1536-5-S1-S20","article-title":"Primary myelofibrosis and the \u201cbad seeds in bad soil\u201d concept.","volume":"5","author":"Le Bousse-Kerdil\u00e8s","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"24","key":"2019111903402473700_B4","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2011-04-348144","article-title":"TNF\u03b1 facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms.","volume":"118","author":"Fleischman","year":"2011","journal-title":"Blood"},{"issue":"4","key":"2019111903402473700_B5","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1600-0609.2012.01836.x","article-title":"Polymorphisms of tumor necrosis factor gene in primary myelofibrosis.","volume":"89","author":"Liu","year":"2012","journal-title":"Eur J Haematol"},{"issue":"4","key":"2019111903402473700_B6","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ajh.23406","article-title":"Associations and prognostic interactions between circulating levels of hepcidin, ferritin and inflammatory cytokines in primary myelofibrosis.","volume":"88","author":"Pardanani","year":"2013","journal-title":"Am J Hematol"},{"issue":"2","key":"2019111903402473700_B7","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cytogfr.2013.01.004","article-title":"The role of cytokines in the initiation and progression of myelofibrosis.","volume":"24","author":"Hasselbalch","year":"2013","journal-title":"Cytokine Growth Factor Rev"},{"issue":"8","key":"2019111903402473700_B8","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/onc.2010.479","article-title":"Anti-inflammatory cytokines hepatocyte growth factor and interleukin-11 are over-expressed in Polycythemia vera and contribute to the growth of clonal erythroblasts independently of JAK2V617F.","volume":"30","author":"Boissinot","year":"2011","journal-title":"Oncogene"},{"issue":"5","key":"2019111903402473700_B9","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.exphem.2014.01.006","article-title":"Cytokine profiles in polycythemia vera and essential thrombocythemia patients: clinical implications.","volume":"42","author":"Pourcelot","year":"2014","journal-title":"Exp Hematol"},{"issue":"1","key":"2019111903402473700_B10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3109\/10428194.2010.531413","article-title":"Increased serum levels of neutrophil gelatinase-associated lipocalin in patients with essential thrombocythemia and polycythemia vera.","volume":"52","author":"Allegra","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"19","key":"2019111903402473700_B11","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1182\/blood-2014-04-570572","article-title":"JAK2V617F+myeloproliferative neoplasm clones evoke paracrine DNA damage to adjacent normal cells through secretion of lipocalin-2.","volume":"124","author":"Kagoya","year":"2014","journal-title":"Blood"},{"issue":"13","key":"2019111903402473700_B12","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1182\/blood-2013-12-544197","article-title":"miRNA-mRNA integrative analysis in primary myelofibrosis CD34+ cells: role of miR-155\/JARID2 axis in abnormal megakaryopoiesis.","volume":"124","author":"Norfo","year":"2014","journal-title":"Blood"},{"issue":"9","key":"2019111903402473700_B13","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1056\/NEJMoa1403141","article-title":"Two clinical phenotypes in polycythemia vera.","volume":"371","author":"Spivak","year":"2014","journal-title":"N Engl J Med"},{"issue":"47","key":"2019111903402473700_B14","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1038\/onc.2008.209","article-title":"Lipocalin 2 is required for BCR-ABL-induced tumorigenesis.","volume":"27","author":"Leng","year":"2008","journal-title":"Oncogene"},{"issue":"9","key":"2019111903402473700_B15","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2009-09-245837","article-title":"A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment).","volume":"115","author":"Passamonti","year":"2010","journal-title":"Blood"},{"issue":"4","key":"2019111903402473700_B16","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1200\/JCO.2010.32.2446","article-title":"DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.","volume":"29","author":"Gangat","year":"2011","journal-title":"J Clin Oncol"},{"issue":"9","key":"2019111903402473700_B17","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1182\/blood-2006-04-017392","article-title":"Involvement of various hematopoietic-cell lineages by the JAK2V617F mutation in polycythemia vera.","volume":"108","author":"Ishii","year":"2006","journal-title":"Blood"},{"issue":"7","key":"2019111903402473700_B18","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.cell.2005.10.027","article-title":"A cell-surface receptor for lipocalin 24p3 selectively mediates apoptosis and iron uptake.","volume":"123","author":"Devireddy","year":"2005","journal-title":"Cell"},{"issue":"1","key":"2019111903402473700_B19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/scd.2010.0040","article-title":"Markers distinguishing mesenchymal stem cells from fibroblasts are downregulated with passaging.","volume":"20","author":"Halfon","year":"2011","journal-title":"Stem Cells Dev"},{"key":"2019111903402473700_B20","doi-asserted-by":"crossref","first-page":"269","DOI":"10.22203\/eCM.v028a19","article-title":"Role and regulation of RUNX2 in osteogenesis.","volume":"28","author":"Bruderer","year":"2014","journal-title":"Eur Cell Mater"},{"issue":"5","key":"2019111903402473700_B21","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nrc1877","article-title":"Fibroblasts in cancer.","volume":"6","author":"Kalluri","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2019111903402473700_B22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bone.2014.06.027","article-title":"Identification of differentiation-stage specific markers that define the ex vivo osteoblastic phenotype.","volume":"67","author":"Twine","year":"2014","journal-title":"Bone"},{"key":"2019111903402473700_B23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.abb.2014.05.003","article-title":"Osteoblast and osteocyte: games without frontiers.","volume":"561","author":"Capulli","year":"2014","journal-title":"Arch Biochem Biophys"},{"issue":"1","key":"2019111903402473700_B24","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10238-011-0170-5","article-title":"Expression of vascular endothelial growth factor in normal, osteoarthritic and osteoporotic osteoblasts.","volume":"13","author":"Corrado","year":"2013","journal-title":"Clin Exp Med"},{"issue":"5","key":"2019111903402473700_B25","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1046\/j.1365-2362.2000.00645.x","article-title":"Production and action of transforming growth factor-beta in human osteoblast cultures: dependence on cell differentiation and modulation by calcitriol.","volume":"30","author":"Kassem","year":"2000","journal-title":"Eur J Clin Invest"},{"issue":"2","key":"2019111903402473700_B26","doi-asserted-by":"crossref","first-page":"272","DOI":"10.7150\/ijbs.2929","article-title":"TGF-\u03b2 and BMP signaling in osteoblast differentiation and bone formation.","volume":"8","author":"Chen","year":"2012","journal-title":"Int J Biol Sci"},{"issue":"Pt 18","key":"2019111903402473700_B27","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1242\/jcs.118596","article-title":"Bmp2 in osteoblasts of periosteum and trabecular bone links bone formation to vascularization and mesenchymal stem cells.","volume":"126","author":"Yang","year":"2013","journal-title":"J Cell Sci"},{"key":"2019111903402473700_B28","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/B978-0-12-800263-6.00004-5","article-title":"Neutrophil gelatinase-associated lipocalin in cancer.","volume":"64","author":"Lippi","year":"2014","journal-title":"Adv Clin Chem"},{"issue":"10","key":"2019111903402473700_B29","doi-asserted-by":"crossref","first-page":"3913","DOI":"10.1073\/pnas.0810617106","article-title":"Lipocalin 2 promotes breast cancer progression.","volume":"106","author":"Yang","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"2019111903402473700_B30","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.18632\/oncotarget.1738","article-title":"Roles of neutrophil gelatinase-associated lipocalin (NGAL) in human cancer.","volume":"5","author":"Candido","year":"2014","journal-title":"Oncotarget"},{"issue":"4","key":"2019111903402473700_B31","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000360689","article-title":"Neutrophil gelatinase-associated lipocalin: ready for routine clinical use? An international perspective.","volume":"37","author":"Ronco","year":"2014","journal-title":"Blood Purif"},{"issue":"1","key":"2019111903402473700_B32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1755-1536-6-19","article-title":"Experimental liver fibrosis research: update on animal models, legal issues and translational aspects.","volume":"6","author":"Liedtke","year":"2013","journal-title":"Fibrogenesis Tissue Repair"},{"issue":"6","key":"2019111903402473700_B33","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1183\/09031936.00192613","article-title":"Neutrophil gelatinase-associated lipocalin in idiopathic pulmonary fibrosis.","volume":"43","author":"Ikezoe","year":"2014","journal-title":"Eur Respir J"},{"issue":"7","key":"2019111903402473700_B34","doi-asserted-by":"crossref","first-page":"4808","DOI":"10.1074\/jbc.M111.275719","article-title":"Lipocalin-2 induces cardiomyocyte apoptosis by increasing intracellular iron accumulation.","volume":"287","author":"Xu","year":"2012","journal-title":"J Biol Chem"},{"issue":"2","key":"2019111903402473700_B35","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/jcp.21334","article-title":"Lipocalin 2-mediated growth suppression is evident in human erythroid and monocyte\/macrophage lineage cells.","volume":"215","author":"Miharada","year":"2008","journal-title":"J Cell Physiol"},{"issue":"2","key":"2019111903402473700_B36","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-2141.1999.01352.x","article-title":"Expression of matrix metalloproteinases (MMP-2 and -9) and tissue inhibitors of metalloproteinases (TIMP-1 and -2) in acute myelogenous leukaemia blasts: comparison with normal bone marrow cells.","volume":"105","author":"Janowska-Wieczorek","year":"1999","journal-title":"Br J Haematol"},{"issue":"10","key":"2019111903402473700_B37","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood.V89.10.3503","article-title":"Granules of the human neutrophilic polymorphonuclear leukocyte.","volume":"89","author":"Borregaard","year":"1997","journal-title":"Blood"},{"issue":"2","key":"2019111903402473700_B38","doi-asserted-by":"crossref","first-page":"796","DOI":"10.3390\/cancers6020796","article-title":"Neutrophil gelatinase-associated lipocalin (NGAL), pro-matrix metalloproteinase-9 (pro-MMP-9) and their complex pro-MMP-9\/NGAL in leukaemias.","volume":"6","author":"Bouchet","year":"2014","journal-title":"Cancers (Basel)"},{"issue":"12","key":"2019111903402473700_B39","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1182\/blood-2007-07-099184","article-title":"JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.","volume":"110","author":"Barosi","year":"2007","journal-title":"Blood"},{"issue":"7","key":"2019111903402473700_B40","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/emboj.2009.35","article-title":"Transcription and signalling pathways involved in BCR-ABL-mediated misregulation of 24p3 and 24p3R.","volume":"28","author":"Sheng","year":"2009","journal-title":"EMBO J"},{"issue":"9","key":"2019111903402473700_B41","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1056\/NEJM199802263380903","article-title":"Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera.","volume":"338","author":"Moliterno","year":"1998","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111903402473700_B42","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1182\/blood.V94.8.2555.420k14_2555_2561","article-title":"Posttranslational processing of the thrombopoietin receptor is impaired in polycythemia vera.","volume":"94","author":"Moliterno","year":"1999","journal-title":"Blood"},{"issue":"20","key":"2019111903402473700_B43","doi-asserted-by":"crossref","first-page":"4625","DOI":"10.1182\/blood-2011-08-372524","article-title":"Thrombopoietin receptor down-modulation by JAK2 V617F: restoration of receptor levels by inhibitors of pathologic JAK2 signaling and of proteasomes.","volume":"119","author":"Pecquet","year":"2012","journal-title":"Blood"},{"issue":"29","key":"2019111903402473700_B44","doi-asserted-by":"crossref","first-page":"27251","DOI":"10.1074\/jbc.M501376200","article-title":"Janus kinases affect thrombopoietin receptor cell surface localization and stability.","volume":"280","author":"Royer","year":"2005","journal-title":"J Biol Chem"},{"issue":"11","key":"2019111903402473700_B45","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1038\/leu.2013.102","article-title":"A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression.","volume":"27","author":"Marty","year":"2013","journal-title":"Leukemia"},{"issue":"4","key":"2019111903402473700_B46","first-page":"1245","article-title":"Bone marrow angiogenesis: methods of quantification and changes evolving in chronic myeloproliferative disorders.","volume":"19","author":"Kvasnicka","year":"2004","journal-title":"Histol Histopathol"},{"issue":"6","key":"2019111903402473700_B47","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1309\/7A5JU9KJK89VQPH9","article-title":"Studies of the site and distribution of CD34+ cells in idiopathic myelofibrosis.","volume":"123","author":"Ni","year":"2005","journal-title":"Am J Clin Pathol"},{"issue":"2","key":"2019111903402473700_B48","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1309\/4YGKED5LWFW4AVDV","article-title":"Quantitative evaluation of bone marrow angiogenesis in idiopathic myelofibrosis.","volume":"126","author":"Ni","year":"2006","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"2019111903402473700_B49","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2141.2005.05573.x","article-title":"Osteosclerosis in advanced chronic idiopathic myelofibrosis is associated with endothelial overexpression of osteoprotegerin.","volume":"130","author":"Bock","year":"2005","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111903402473700_B50","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1600-0609.2007.00852.x","article-title":"Bone changes in myelofibrosis with myeloid metaplasia: a histomorphometric and microcomputed tomographic study.","volume":"78","author":"Schmidt","year":"2007","journal-title":"Eur J Haematol"},{"issue":"3","key":"2019111903402473700_B51","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.stem.2013.06.009","article-title":"Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche.","volume":"13","author":"Schepers","year":"2013","journal-title":"Cell Stem Cell"},{"issue":"2","key":"2019111903402473700_B52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.devcel.2010.07.010","article-title":"Osteoblast precursors, but not mature osteoblasts, move into developing and fractured bones along with invading blood vessels.","volume":"19","author":"Maes","year":"2010","journal-title":"Dev Cell"},{"issue":"3","key":"2019111903402473700_B53","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s11914-007-0024-y","article-title":"The RANKL\/RANK\/OPG pathway.","volume":"5","author":"Boyce","year":"2007","journal-title":"Curr Osteoporos Rep"},{"issue":"4","key":"2019111903402473700_B54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000047804","article-title":"Reactive oxygen species as intracellular messengers during cell growth and differentiation.","volume":"11","author":"Sauer","year":"2001","journal-title":"Cell Physiol Biochem"},{"issue":"10","key":"2019111903402473700_B55","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1002\/jcp.24071","article-title":"Oxidases and reactive oxygen species during hematopoiesis: a focus on megakaryocytes.","volume":"227","author":"Eliades","year":"2012","journal-title":"J Cell Physiol"},{"issue":"22","key":"2019111903402473700_B56","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1242\/dev.107086","article-title":"Stem cells and the impact of ROS signaling.","volume":"141","author":"Bigarella","year":"2014","journal-title":"Development"},{"issue":"10","key":"2019111903402473700_B57","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/jcb.24582","article-title":"Protective effect of melatonin on bone marrow mesenchymal stem cells against hydrogen peroxide-induced apoptosis in vitro.","volume":"114","author":"Wang","year":"2013","journal-title":"J Cell Biochem"},{"key":"2019111903402473700_B58","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-213X-14-21","article-title":"TGF-\u03b21 induces senescence of bone marrow mesenchymal stem cells via increase of mitochondrial ROS production.","volume":"14","author":"Wu","year":"2014","journal-title":"BMC Dev Biol"},{"key":"2019111903402473700_B59","doi-asserted-by":"crossref","first-page":"e844","DOI":"10.1038\/cddis.2013.338","article-title":"Autophagy prevents irradiation injury and maintains stemness through decreasing ROS generation in mesenchymal stem cells.","volume":"4","author":"Hou","year":"2013","journal-title":"Cell Death Dis"},{"key":"2019111903402473700_B60","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.fct.2013.06.013","article-title":"ROS-major mediators of extracellular matrix remodeling during tumor progression.","volume":"61","author":"Nikitovic","year":"2013","journal-title":"Food Chem Toxicol"},{"issue":"6 pt B","key":"2019111903402473700_B61","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.semcancer.2013.08.007","article-title":"Tumor and its microenvironment: a synergistic interplay.","volume":"23","author":"Catalano","year":"2013","journal-title":"Semin Cancer Biol"},{"issue":"7-8","key":"2019111903402473700_B62","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.lfs.2011.06.007","article-title":"Reactive oxygen species mediate adipocyte differentiation in mesenchymal stem cells.","volume":"89","author":"Kanda","year":"2011","journal-title":"Life Sci"},{"issue":"3","key":"2019111903402473700_B63","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/stem.302","article-title":"Reactive oxygen species inhibit adhesion of mesenchymal stem cells implanted into ischemic myocardium via interference of focal adhesion complex.","volume":"28","author":"Song","year":"2010","journal-title":"Stem Cells"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/8\/972\/1391659\/972.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/126\/8\/972\/1391659\/972.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T23:17:00Z","timestamp":1652138220000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/126\/8\/972\/34721\/Lipocalin-produced-by-myelofibrosis-cells-affects"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,20]]},"references-count":63,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8,20]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2014-12-618595","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,20]]}}}